终末期肾病患者因COVID-19住院的结局
这项回顾性研究比较了纽约13家医院收治的COVID-19患者中合并与不合并终末期肾病(ESKD)者的结局。在10482例患者中,419例有ESKD;ESKD患者院内死亡率更高(31.7% vs 25.4%,OR 1.38,95%CI 1.12-1.70),调整后仍显著(aOR 1.37,1.09-1.73),且住院≥7天的 odds 更高,但机械通气无差异。
要点
- 合并ESKD的COVID-19住院患者院内死亡率显著高于无ESKD者。
- ESKD患者住院≥7天的 odds 更高,但机械通气风险无差异。
- ESKD患者院内死亡的独立危险因素包括年龄增长、使用呼吸机、淋巴细胞减少、BUN和铁蛋白升高。
核心结论
- 在因COVID-19住院的患者中,合并ESKD者院内死亡率高于不合并ESKD者,且调整人口学和合并症后关联仍存在。
研究设计与样本
- 回顾性研究,纳入2020年3月1日至4月27日纽约13家医院收治的COVID-19患者10482例,随访至2020年5月27日,其中419例有ESKD。
主要发现
- ESKD患者院内死亡率为31.7%,无ESKD者为25.4%,粗OR 1.38(95%CI 1.12-1.70)。
- 调整人口学和合并症后,ESKD与院内死亡的aOR为1.37(95%CI 1.09-1.73)。
- ESKD患者住院≥7天的粗OR为1.62(95%CI 1.27-2.06),调整后OR为1.57(95%CI 1.22-2.02)。
- 两组机械通气 odds 无差异。
- ESKD患者院内死亡的独立危险因素包括年龄增长、使用呼吸机、淋巴细胞减少、血尿素氮和血清铁蛋白升高;Black种族与死亡风险降低相关。
临床怎么用
- 对合并ESKD的COVID-19住院患者应加强死亡风险评估和监测,尤其关注年龄、呼吸机使用、淋巴细胞减少、BUN和铁蛋白升高者。
局限性
- 回顾性研究设计可能存在残余混杂。
- 研究仅纳入纽约13家医院的患者,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Given the high risk of infection-related mortality, patients with end-stage kidney disease (ESKD) may be at increased risk with COVID-19. To assess this, we compared outcomes of patients with and without ESKD, hospitalized with COVID-19. This was a retrospective study of patients admitted with COVID-19 from 13 New York hospitals from March 1, 2020, to April 27, 2020, and followed through May 27, 2020. We measured primary outcome (in-hospital death), and secondary outcomes (mechanical ventilation and length of stay). Of 10,482 patients with COVID-19, 419 had ESKD. Patients with ESKD were older, had a greater percentage self-identified as Black, and more comorbid conditions. Patients with ESKD had a higher rate of in-hospital death than those without (31.7% vs 25.4%, odds ratio 1.38, 95% confidence interval 1.12 - 1.70). This increase rate remained after adjusting for demographic and comorbid conditions (adjusted odds ratio 1.37, 1.09 - 1.73). The odds of length of stay of seven or more days was higher in the group with compared to the group without ESKD in both the crude and adjusted analysis (1.62, 1.27 - 2.06; vs 1.57, 1.22 - 2.02, respectively). There was no difference in the odds of mechanical ventilation between the groups. Independent risk factors for in-hospital death for patients with ESKD were increased age, being on a ventilator, lymphopenia, blood urea nitrogen and serum ferritin. Black race was associated with a lower risk of death. Thus, among patients hospitalized with COVID-19, those with ESKD had a higher rate of in-hospital death compared to those without ESKD.
引用
- Ng JH, Hirsch JS, Wanchoo R, et al. Outcomes of patients with end-stage kidney disease hospitalized with COVID-19. Kidney Int. 2020. PMID: 32810523. doi:10.1016/j.kint.2020.07.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。